Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Che Wu

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Therapeutic Advances in Medical Oncology|December 17, 2024
Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitorsLiang-Yun Cheng, Po-Jung Su, Ming-Chun Kuo, et al.
Annals of Coloproctology|March 9, 2026
Survival impact of radiotherapy for patients with de novo metastatic rectal cancerHarvey Yu-Li Su, Yun-Hsuan Lin, Ko-Chao Lee, et al.
BMC Cancer|September 15, 2023
The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapyTsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, et al.
Journal for Immunotherapy of Cancer|July 7, 2026
Oncogenic <i>PIK3CA</i> mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinomaYu-Li Su, Shih-Yu Huang, Chung-Wen Kuo, et al.
Journal of Biomedicine & Biotechnology|December 15, 2010
Identification of a new peptide for fibrosarcoma tumor targeting and imaging in vivoChia-Che Wu, Erh-Hsuan Lin, Yu-Ching Lee, et al.
Medicine|February 18, 2016
Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in TaiwanJin-Hua Chen, Yu-Chun Yen, Shing-Hwa Liu, et al.
Medicine|April 9, 2016
Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity IndexJin-Hua Chen, Yu-Chun Yen, Hsuan-Chia Yang, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Therapeutic Advances in Medical Oncology|December 17, 2024
Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitorsLiang-Yun Cheng, Po-Jung Su, Ming-Chun Kuo, et al.
Annals of Coloproctology|March 9, 2026
Survival impact of radiotherapy for patients with de novo metastatic rectal cancerHarvey Yu-Li Su, Yun-Hsuan Lin, Ko-Chao Lee, et al.
BMC Cancer|September 15, 2023
The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapyTsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, et al.
Journal for Immunotherapy of Cancer|July 7, 2026
Oncogenic <i>PIK3CA</i> mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinomaYu-Li Su, Shih-Yu Huang, Chung-Wen Kuo, et al.
Journal of Biomedicine & Biotechnology|December 15, 2010
Identification of a new peptide for fibrosarcoma tumor targeting and imaging in vivoChia-Che Wu, Erh-Hsuan Lin, Yu-Ching Lee, et al.
Medicine|February 18, 2016
Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in TaiwanJin-Hua Chen, Yu-Chun Yen, Shing-Hwa Liu, et al.
Medicine|April 9, 2016
Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity IndexJin-Hua Chen, Yu-Chun Yen, Hsuan-Chia Yang, et al.
Pageof 6